Cristina Tomarchio

Catania, 95123, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.

Journal: Pharmaceutics
Published: June 29, 2026

Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.

Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.

Journal: Critical reviews in oncology/hematology
Published: April 10, 2026

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.

Journal: Frontiers in pharmacology
Published: January 03, 2026

Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Journal: Genes
Published: December 13, 2025

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

Journal: International journal of molecular sciences
Published: June 15, 2025

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

Journal: International journal of molecular sciences
Published: December 23, 2024

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.

Journal: Biomolecules
Published: September 03, 2024

In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients.

In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients.

Journal: Genes
Published: June 28, 2024

Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer.

Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer.

Journal: Genes
Published: May 22, 2023

High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.

High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.

Journal: OncoTargets and therapy
Published: April 06, 2023

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients.

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients.

Journal: Diagnostics (Basel, Switzerland)
Published: April 02, 2022

A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic.

A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic.

Journal: Diagnostics (Basel, Switzerland)
Published: June 30, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026